Table of Contents

1 Study Coverage

• 1.1 Galantamine Hydrobromide Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Galantamine Hydrobromide Market Size Growth Rate by Product
  • 1.4.2 ≥ 98%
  • 1.4.3 ＜ 98%
• 1.5 Market by End User
  • 1.5.1 Global Galantamine Hydrobromide Market Size Growth Rate by End User
  • 1.5.2 Tablet
  • 1.5.3 Capsule
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Galantamine Hydrobromide Market Size
  • 2.1.1 Global Galantamine Hydrobromide Revenue 2014-2025
  • 2.1.2 Global Galantamine Hydrobromide Sales 2014-2025
• 2.2 Galantamine Hydrobromide Growth Rate by Regions
  • 2.2.1 Global Galantamine Hydrobromide Sales by Regions
  • 2.2.2 Global Galantamine Hydrobromide Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Galantamine Hydrobromide Sales by Manufacturers
  • 3.1.1 Galantamine Hydrobromide Sales by Manufacturers
  • 3.1.2 Galantamine Hydrobromide Sales Market Share by Manufacturers
  • 3.1.3 Global Galantamine Hydrobromide Market Concentration Ratio (CR5 and HHI)
• 3.2 Galantamine Hydrobromide Revenue by Manufacturers
  • 3.2.1 Galantamine Hydrobromide Revenue by Manufacturers (2014-2019)
  • 3.2.2 Galantamine Hydrobromide Revenue Share by Manufacturers (2014-2019)
• 3.3 Galantamine Hydrobromide Price by Manufacturers
• 3.4 Galantamine Hydrobromide Manufacturing Base Distribution, Product Types
  • 3.4.1 Galantamine Hydrobromide Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Galantamine Hydrobromide Product Type
  • 3.4.3 Date of International Manufacturers Enter into Galantamine Hydrobromide Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Galantamine Hydrobromide Sales by Product
• 4.2 Global Galantamine Hydrobromide Revenue by Product
• 4.3 Galantamine Hydrobromide Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Galantamine Hydrobromide Breakdown Data by End User

6 North America

• 6.1 North America Galantamine Hydrobromide by Countries
  • 6.1.1 North America Galantamine Hydrobromide Sales by Countries
  • 6.1.2 North America Galantamine Hydrobromide Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Galantamine Hydrobromide by Product
• 6.3 North America Galantamine Hydrobromide by End User

7 Europe

• 7.1 Europe Galantamine Hydrobromide by Countries
  • 7.1.1 Europe Galantamine Hydrobromide Sales by Countries
  • 7.1.2 Europe Galantamine Hydrobromide Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Galantamine Hydrobromide by Product
• 7.3 Europe Galantamine Hydrobromide by End User

8 Asia Pacific

• 8.1 Asia Pacific Galantamine Hydrobromide by Countries
  • 8.1.1 Asia Pacific Galantamine Hydrobromide Sales by Countries
  • 8.1.2 Asia Pacific Galantamine Hydrobromide Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Galantamine Hydrobromide by Product
• 8.3 Asia Pacific Galantamine Hydrobromide by End User

9 Central & South America

• 9.1 Central & South America Galantamine Hydrobromide by Countries
  • 9.1.1 Central & South America Galantamine Hydrobromide Sales by Countries
  • 9.1.2 Central & South America Galantamine Hydrobromide Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Galantamine Hydrobromide by Product
• 9.3 Central & South America Galantamine Hydrobromide by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Galantamine Hydrobromide by Countries
  • 10.1.1 Middle East and Africa Galantamine Hydrobromide Sales by Countries
  • 10.1.2 Middle East and Africa Galantamine Hydrobromide Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Galantamine Hydrobromide by Product
• 10.3 Middle East and Africa Galantamine Hydrobromide by End User

11 Company Profiles

• 11.1 Sun Pharmaceutical Industries
  • 11.1.1 Sun Pharmaceutical Industries Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Sun Pharmaceutical Industries Galantamine Hydrobromide Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Sun Pharmaceutical Industries Galantamine Hydrobromide Products Offered
  • 11.1.5 Sun Pharmaceutical Industries Recent Development
• 11.2 Tapi Teva
  • 11.2.1 Tapi Teva Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Tapi Teva Galantamine Hydrobromide Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Tapi Teva Galantamine Hydrobromide Products Offered
  • 11.2.5 Tapi Teva Recent Development
• 11.3 Menovo Pharmaceutical
  • 11.3.1 Menovo Pharmaceutical Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Menovo Pharmaceutical Galantamine Hydrobromide Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Menovo Pharmaceutical Galantamine Hydrobromide Products Offered
  • 11.3.5 Menovo Pharmaceutical Recent Development

12 Future Forecast

• 12.1 Galantamine Hydrobromide Market Forecast by Regions
  • 12.1.1 Global Galantamine Hydrobromide Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Galantamine Hydrobromide Revenue Forecast by Regions 2019-2025
• 12.2 Galantamine Hydrobromide Market Forecast by Product
  • 12.2.1 Global Galantamine Hydrobromide Sales Forecast by Product 2019-2025
  • 12.2.2 Global Galantamine Hydrobromide Revenue Forecast by Product 2019-2025
• 12.3 Galantamine Hydrobromide Market Forecast by End User
• 12.4 North America Galantamine Hydrobromide Forecast
• 12.5 Europe Galantamine Hydrobromide Forecast
• 12.6 Asia Pacific Galantamine Hydrobromide Forecast
• 12.7 Central & South America Galantamine Hydrobromide Forecast
• 12.8 Middle East and Africa Galantamine Hydrobromide Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Galantamine Hydrobromide Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Galantamine hydrobromide belongs to the class of substances called nootropic agents and is used for the treatment of mild to moderate dementia of the Alzheimer's type.
The global Galantamine Hydrobromide market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Galantamine Hydrobromide market based on company, product type, end user and key regions.

This report studies the global market size of Galantamine Hydrobromide in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Galantamine Hydrobromide in these regions.
This research report categorizes the global Galantamine Hydrobromide market by top players/brands, region, type and end user. This report also studies the global Galantamine Hydrobromide market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sun Pharmaceutical Industries
Tapi Teva
Menovo Pharmaceutical

Market size by Product
≥ 98%
＜ 98%
Market size by End User
Tablet
Capsule
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Galantamine Hydrobromide market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Galantamine Hydrobromide market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Galantamine Hydrobromide companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Galantamine Hydrobromide submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Galantamine Hydrobromide are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Galantamine Hydrobromide market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.